Bulk ingredients

Cambrex doubles footprint at its crystallization facility

01-Aug-2019 By Vassia Barba

Cambrex to scale up its solid form screening and crystallization process development facility in Edinburgh to answer market demand for larger scale crystallization.

Gene therapy manufacturing partnership to support ‘booming’ market

03-Dec-2018 By Maggie Lynch

Axovant has signed a strategic partnership agreement with the CDMO Yposkesi to support its growing gene therapy pipeline.

Supply chain summed up: Innovations, partnerships, and deals in 2018

13-Nov-2018 By Maggie Lynch

Supply chain companies have been busy in 2018. Here, we're wrapping up some of the big moves made over the last year.

AAPS PharmSci 360 preview: ‘Small-conference feel and big-conference breadth’

30-Oct-2018 By Melissa Fassbender

AAPS PharmSci 360 is a new conference this year, created in response to a desire for “fresh science,” specifically with chemical and biomolecular components. So what can you expect?

Cambrex cements North Carolina presence with buildings purchase

01-Oct-2018 By Maggie Lynch

Cambrex, a small molecule and API manufacturer, announced it will expand to establish a ‘center of excellence’ for process and development of its API clinical supply.

State of the Industry

State of the Industry: Taking the pulse of the contract services market

11-Jun-2018 By Melissa Fassbender

Following on from the success of last year's survey, Outsourcing-Pharma is running another 'state of the industry' survey to gauge views about the current state of the pharmaceutical contract services industry.

AMRI awarded seven-year NIH contract

06-Jun-2018 By Melissa Fassbender

AMRI will support the development and manufacture of active pharmaceutical ingredients (API) and drug product for Phase I clinical studies under a seven-year contract with the NIH.

WuXi AppTec IPO tops $353m

09-May-2018 By Melissa Fassbender

The Chinese contract research and development company WuXi AppTec has raised more than $353m in its initial public offering of common stock on the Shanghai Stock Exchange.

Researchers commercializing new method to accelerate drug development

03-May-2018 By Melissa Fassbender

A new method for determining the crystal structures of organic salts – which make up 40% of all APIs – could “greatly speed up” the drug development process, say researchers.

DCAT WEEK

CMOs, CDMOs give company updates at DCAT Week: Acquisitions, expansions on all sides

29-Mar-2018 By Melissa Fassbender

At DCAT Week, contract manufacturing and development companies from across the globe shared updates and news – from multi-million dollar investments to new business structures and areas of focus.

The Good, The Bad and the Ugly of CMO partnerships: A biotech perspective

13-Mar-2018 By Flora Southey

Partnering with CMOs makes sense for emerging biotechs, says Ardelyx exec James Kanter, who relies on networking and clear communication guidelines to manage third-party relationships.

People on the move

Outsourcing-Pharma’s Hiring and Firing Roundup February ‘18

28-Feb-2018 By Melissa Fassbender

CordenPharma has revamped its executive leadership team, Recipharm has named the head of its new global development organization, and several new CEOs have been appointed.

Scientist.com implementing process to address global requirements ahead of GDPR

19-Feb-2018 By Melissa Fassbender

Scientist.com is working to implement an improved contractual landscape ahead of GDPR implementation in May, in order to ensure global compliance among sponsors and CROs.

Cambrex up on innovator API demand, aims for double-digit growth

12-Feb-2018 By Dan Stanton

Cambrex Corporation says a preference among reference drugmakers for Western made APIs has helped produce robust quarterly results.

News in brief

BioDuro teams up with API developer Porton

01-Feb-2018 By Melissa Fassbender

The San Diego-CA-based contract research, development, and manufacturing organization (CDMO), BioDuro, has announced a cooperation agreement with Porton Pharma Solutions.